34 related articles for article (PubMed ID: 9395452)
1. Expression, purification, crystallization and preliminary X-ray analysis of the Met244Ala variant of catalase-peroxidase (KatG) from the haloarchaeon Haloarcula marismortui.
Ten-I T; Kumasaka T; Higuchi W; Tanaka S; Yoshimatsu K; Fujiwara T; Sato T
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Nov; 63(Pt 11):940-3. PubMed ID: 18007045
[TBL] [Abstract][Full Text] [Related]
2. Degradation Mechanism of Aflatoxin M
Liu X; Zhao F; Wang X; Peng K; Kang C; Sang Y
Foods; 2024 Mar; 13(6):. PubMed ID: 38540878
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a catalase-peroxidase variant (L333V-KatG) identified in an INH-resistant
Uribe-Vázquez B; Díaz-Vilchis A; Avila-Linares A; Saab-Rincón G; Marín-Tovar Y; Flores H; Pastor N; Huerta-Miranda G; Rudiño-Piñera E; Soberón X
Biochem Biophys Rep; 2024 Mar; 37():101649. PubMed ID: 38318524
[No Abstract] [Full Text] [Related]
4. Different Schiff Bases-Structure, Importance and Classification.
Raczuk E; Dmochowska B; Samaszko-Fiertek J; Madaj J
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164049
[TBL] [Abstract][Full Text] [Related]
5. Enzyme reactivation by hydrogen peroxide in heme-based tryptophan dioxygenase.
Fu R; Gupta R; Geng J; Dornevil K; Wang S; Zhang Y; Hendrich MP; Liu A
J Biol Chem; 2011 Jul; 286(30):26541-54. PubMed ID: 21632548
[TBL] [Abstract][Full Text] [Related]
6. Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars.
Westwood IM; Bhakta S; Russell AJ; Fullam E; Anderton MC; Kawamura A; Mulvaney AW; Vickers RJ; Bhowruth V; Besra GS; Lalvani A; Davies SG; Sim E
Protein Cell; 2010 Jan; 1(1):82-95. PubMed ID: 21204000
[TBL] [Abstract][Full Text] [Related]
7. Relationship between mutation of serine residue at 315th position in M. tuberculosis catalase-peroxidase enzyme and Isoniazid susceptibility: an in silico analysis.
Purohit R; Rajendran V; Sethumadhavan R
J Mol Model; 2011 Apr; 17(4):869-77. PubMed ID: 20593210
[TBL] [Abstract][Full Text] [Related]
8. A radical on the Met-Tyr-Trp modification required for catalase activity in catalase-peroxidase is established by isotopic labeling and site-directed mutagenesis.
Zhao X; Suarez J; Khajo A; Yu S; Metlitsky L; Magliozzo RS
J Am Chem Soc; 2010 Jun; 132(24):8268-9. PubMed ID: 20507091
[TBL] [Abstract][Full Text] [Related]
9. Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.
Ando H; Kondo Y; Suetake T; Toyota E; Kato S; Mori T; Kirikae T
Antimicrob Agents Chemother; 2010 May; 54(5):1793-9. PubMed ID: 20211896
[TBL] [Abstract][Full Text] [Related]
10. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities.
Cade CE; Dlouhy AC; Medzihradszky KF; Salas-Castillo SP; Ghiladi RA
Protein Sci; 2010 Mar; 19(3):458-74. PubMed ID: 20054829
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance in Mycobacterium tuberculosis: peroxidase intermediate bypass causes poor isoniazid activation by the S315G mutant of M. tuberculosis catalase-peroxidase (KatG).
Suarez J; Ranguelova K; Schelvis JPM; Magliozzo RS
J Biol Chem; 2009 Jun; 284(24):16146-16155. PubMed ID: 19363028
[TBL] [Abstract][Full Text] [Related]
12. Detection of multidrug resistance in Mycobacterium tuberculosis.
Sekiguchi J; Miyoshi-Akiyama T; Augustynowicz-Kopeć E; Zwolska Z; Kirikae F; Toyota E; Kobayashi I; Morita K; Kudo K; Kato S; Kuratsuji T; Mori T; Kirikae T
J Clin Microbiol; 2007 Jan; 45(1):179-92. PubMed ID: 17108078
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis.
Song Z; Marzilli L; Greenlee BM; Chen ES; Silver RF; Askin FB; Teirstein AS; Zhang Y; Cotter RJ; Moller DR
J Exp Med; 2005 Mar; 201(5):755-67. PubMed ID: 15753209
[TBL] [Abstract][Full Text] [Related]
14. S-nitroso proteome of Mycobacterium tuberculosis: Enzymes of intermediary metabolism and antioxidant defense.
Rhee KY; Erdjument-Bromage H; Tempst P; Nathan CF
Proc Natl Acad Sci U S A; 2005 Jan; 102(2):467-72. PubMed ID: 15626759
[TBL] [Abstract][Full Text] [Related]
15. Exploring the structure and function of the mycobacterial KatG protein using trans-dominant mutants.
DeVito JA; Morris S
Antimicrob Agents Chemother; 2003 Jan; 47(1):188-95. PubMed ID: 12499190
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional characterization of the Pseudomonas hydroperoxide resistance protein Ohr.
Lesniak J; Barton WA; Nikolov DB
EMBO J; 2002 Dec; 21(24):6649-59. PubMed ID: 12485986
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of recombinant catalase-peroxidase, which confers isoniazid sensitivity in Mycobacterium tuberculosis.
Nagy JM; Cass AE; Brown KA
J Biol Chem; 1997 Dec; 272(50):31265-71. PubMed ID: 9395452
[TBL] [Abstract][Full Text] [Related]
18. Overexpression, purification, and characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosis.
Johnsson K; Froland WA; Schultz PG
J Biol Chem; 1997 Jan; 272(5):2834-40. PubMed ID: 9006925
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid.
Wengenack NL; Uhl JR; St Amand AL; Tomlinson AJ; Benson LM; Naylor S; Kline BC; Cockerill FR; Rusnak F
J Infect Dis; 1997 Sep; 176(3):722-7. PubMed ID: 9291321
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
